In the carbon tetrachloride (CCl4)-induced liver fibrosis model, GCV treatment significantly decreased the population of α-SMA-expressing HSCs in the liver of αSMA-TK mice (Fig. 2A, B). The gene discussed is ACTA1; the disease is Hepatic fibrosis.